News About: Pharm. Industry
EU remains Korea's top drug market
The European Union (EU) is emerging as the largest export market for Korean pharmaceuticals in the years ahead amid declining sales in the South Asian market due to the won's strength, an industry sources said r...
4 arrested for making fake stamina drug
Police arrested recently four people on charges of producing a health food containing tadalafil, a substance of Cialis that is marketed by Lilly Korea for the treatment of erectile dysfunction, and selling them to ori...
Small/medium drug companies seeking survival with R&D.
Small drug companies are trying the company transformation themselves to survive from the forthcoming challenges of the FTA and the positive list system.
It seems to be very likely for the local pharmaceutical ind...
CJ set to take over Hanil Pharm
CJ, the nation's largest food manufacturer, is close to clinching a deal to take over the finance-troubled Hanil Pharm, industry sources and company officials said.
Hanil Pharm signed a memorandum of understanding ...
US RAC recommends approval of clinical protocol for first human test of ViroMed's VM202
Viromed, a local biotech company, said on August 17 that the Recombinant DNA Advisory Committee (RAC) of the National Institutes of Health (NIH) has voted unanimously that the first human clinical study of ViroMed' ge...
First-quarter flagship product sales are in increasing trend
The domestic major pharmaceutical firms saw overall sales growth in the first six-month of this year, fueled by brisk sales of their flagship products.
Market experts said the trend has been mainly attribute...
Business disparity between big and small/medium drug companies on the rise.
The top drug companies have made a great business performance for the sales, gross incomes and ordinary incomes despite a general economic recession these days whereas small and medium sized firms were unable to overc...
SK completed phase III studies for new impotence drug.
SK chemical announced on Aug. 14 that SK-3530, an anti-impotent drug discovered by SK chemical had completed its phase III study.
SK took a joint development of SK-3530 with Intugen, a biotech venture company, si...
Government urged to delay new GMP system
The domestic pharmaceutical industry is calling for the Korea Food and Drug Administration to delay the implementation of a new global good manufacturing practice (GMP) system, while providing an allowance of at least...
Nominal Korean-made drugs may not be granted any longer.
The KFDA announced on Aug. 9 that the KFDA would not grant it as a Korean-made drug when a drug maker imported finished bulk drugs simply to pack locally according to the revised Working Rules of the Pharmaceutical Af...
